Dual irreversible kinase inhibitors: Quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2
Allan Wissner, Heidi L. Fraser, Charles L. Ingalls, Russell G. Dushin, M. Brawner Floyd, Kinwang Cheung, Thomas Nittoli, Malini R. Ravi, Xingzhi Tan, Frank LoganzoVolume:
15
Year:
2007
Language:
english
Pages:
14
DOI:
10.1016/j.bmc.2007.03.055
File:
PDF, 645 KB
english, 2007